RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, announced today the close of a $15 million Series A financing co-led by SPRIM ...

Leukapheresis Market Driven by Rising Blood-Related Disorders, Advanced Technologies, and Growing Demand for Personalized Medicine, the ...

Researchers from Penn State College of Medicine have developed an innovative tool called the Genetic Progression Score (GPS) ...

Now, AI technology can help in early detection of diseases like arthritis and lupus. | Health News | Patrika News ...

We described the first case reported in the literature of multiple myeloma in a young African woman with Systemic lupus and Sjögren Syndrome. The clinician should consider multiple myeloma in young ...

Immunotherapy represents a groundbreaking approach to combating various diseases by harnessing and enhancing the body’s ...

Artificial intelligence (AI) can significantly aid in early detection of autoimmune diseases, like rheumatoid arthritis and ...

New artificial intelligence (AI), the Genetic Progression Score (GPS), accurately predicts autoimmune disease progression, ...

Galapagos will gain full development and commercialization rights to its pipeline, and is subject to single digit royalty ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Healthcare professionals reveal seven effective methods to reduce chronic inflammation, from lifestyle changes to dietary ...

National Resilience, Inc. (Resilience), a technology-driven biomanufacturing leader dedicated to broadening access to complex medicines, today announced the expansion of its collaboration with Parvus ...